Vasoactive Thiomethyl-Pyrimidines: Promising Drug Candidates with Vascular Activity

Bibliographic Details
Main Author: Andrade,Audrey N. de
Publication Date: 2017
Other Authors: Araújo,Alice V., Barbosa,Hugo B. W., Wanderley,Almir G., Malta,Oscar L., Anjos,Janaína V. dos
Format: Article
Language: eng
Source: Journal of the Brazilian Chemical Society (Online)
Download full: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-50532017000701266
Summary: Pyrimidines and their derivatives are present in various biologically active molecules. Most of the synthetic methods employed to achieve the pyrimidinone ring consist of two stages: the synthesis of a Michael intermediate from an aldehyde and an "active methylene" containing compound; and the condensation of this intermediate with a molecule containing an uranium moiety. This may take one to two days of laboratory work. In this paper we describe a new methodology in which these derivatives are obtained via multicomponent synthesis mediated by ultrasound in only 2 hours. In order to obtain water-soluble pyrimidinone derivatives, our previous compounds were further converted into their sodium salts. In pharmacologic studies, these salts inhibited phenylephrine-induced contraction in isolated rat aorta, suggesting that they may act as alpha-1 antagonists and, therefore, are candidates for anti-hypertensive drugs.
id SBQ-2_263bf52e986d672dd605050e84f10f51
oai_identifier_str oai:scielo:S0103-50532017000701266
network_acronym_str SBQ-2
network_name_str Journal of the Brazilian Chemical Society (Online)
repository_id_str
spelling Vasoactive Thiomethyl-Pyrimidines: Promising Drug Candidates with Vascular Activitypyrimidinesvascular activityhypertensiondrug discoveryultrasoundPyrimidines and their derivatives are present in various biologically active molecules. Most of the synthetic methods employed to achieve the pyrimidinone ring consist of two stages: the synthesis of a Michael intermediate from an aldehyde and an "active methylene" containing compound; and the condensation of this intermediate with a molecule containing an uranium moiety. This may take one to two days of laboratory work. In this paper we describe a new methodology in which these derivatives are obtained via multicomponent synthesis mediated by ultrasound in only 2 hours. In order to obtain water-soluble pyrimidinone derivatives, our previous compounds were further converted into their sodium salts. In pharmacologic studies, these salts inhibited phenylephrine-induced contraction in isolated rat aorta, suggesting that they may act as alpha-1 antagonists and, therefore, are candidates for anti-hypertensive drugs.Sociedade Brasileira de Química2017-07-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-50532017000701266Journal of the Brazilian Chemical Society v.28 n.7 2017reponame:Journal of the Brazilian Chemical Society (Online)instname:Sociedade Brasileira de Química (SBQ)instacron:SBQ10.21577/0103-5053.20160289info:eu-repo/semantics/openAccessAndrade,Audrey N. deAraújo,Alice V.Barbosa,Hugo B. W.Wanderley,Almir G.Malta,Oscar L.Anjos,Janaína V. doseng2017-06-23T00:00:00Zoai:scielo:S0103-50532017000701266Revistahttp://jbcs.sbq.org.brONGhttps://old.scielo.br/oai/scielo-oai.php||office@jbcs.sbq.org.br1678-47900103-5053opendoar:2017-06-23T00:00Journal of the Brazilian Chemical Society (Online) - Sociedade Brasileira de Química (SBQ)false
dc.title.none.fl_str_mv Vasoactive Thiomethyl-Pyrimidines: Promising Drug Candidates with Vascular Activity
title Vasoactive Thiomethyl-Pyrimidines: Promising Drug Candidates with Vascular Activity
spellingShingle Vasoactive Thiomethyl-Pyrimidines: Promising Drug Candidates with Vascular Activity
Andrade,Audrey N. de
pyrimidines
vascular activity
hypertension
drug discovery
ultrasound
title_short Vasoactive Thiomethyl-Pyrimidines: Promising Drug Candidates with Vascular Activity
title_full Vasoactive Thiomethyl-Pyrimidines: Promising Drug Candidates with Vascular Activity
title_fullStr Vasoactive Thiomethyl-Pyrimidines: Promising Drug Candidates with Vascular Activity
title_full_unstemmed Vasoactive Thiomethyl-Pyrimidines: Promising Drug Candidates with Vascular Activity
title_sort Vasoactive Thiomethyl-Pyrimidines: Promising Drug Candidates with Vascular Activity
author Andrade,Audrey N. de
author_facet Andrade,Audrey N. de
Araújo,Alice V.
Barbosa,Hugo B. W.
Wanderley,Almir G.
Malta,Oscar L.
Anjos,Janaína V. dos
author_role author
author2 Araújo,Alice V.
Barbosa,Hugo B. W.
Wanderley,Almir G.
Malta,Oscar L.
Anjos,Janaína V. dos
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Andrade,Audrey N. de
Araújo,Alice V.
Barbosa,Hugo B. W.
Wanderley,Almir G.
Malta,Oscar L.
Anjos,Janaína V. dos
dc.subject.por.fl_str_mv pyrimidines
vascular activity
hypertension
drug discovery
ultrasound
topic pyrimidines
vascular activity
hypertension
drug discovery
ultrasound
description Pyrimidines and their derivatives are present in various biologically active molecules. Most of the synthetic methods employed to achieve the pyrimidinone ring consist of two stages: the synthesis of a Michael intermediate from an aldehyde and an "active methylene" containing compound; and the condensation of this intermediate with a molecule containing an uranium moiety. This may take one to two days of laboratory work. In this paper we describe a new methodology in which these derivatives are obtained via multicomponent synthesis mediated by ultrasound in only 2 hours. In order to obtain water-soluble pyrimidinone derivatives, our previous compounds were further converted into their sodium salts. In pharmacologic studies, these salts inhibited phenylephrine-induced contraction in isolated rat aorta, suggesting that they may act as alpha-1 antagonists and, therefore, are candidates for anti-hypertensive drugs.
publishDate 2017
dc.date.none.fl_str_mv 2017-07-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-50532017000701266
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-50532017000701266
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.21577/0103-5053.20160289
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Química
publisher.none.fl_str_mv Sociedade Brasileira de Química
dc.source.none.fl_str_mv Journal of the Brazilian Chemical Society v.28 n.7 2017
reponame:Journal of the Brazilian Chemical Society (Online)
instname:Sociedade Brasileira de Química (SBQ)
instacron:SBQ
instname_str Sociedade Brasileira de Química (SBQ)
instacron_str SBQ
institution SBQ
reponame_str Journal of the Brazilian Chemical Society (Online)
collection Journal of the Brazilian Chemical Society (Online)
repository.name.fl_str_mv Journal of the Brazilian Chemical Society (Online) - Sociedade Brasileira de Química (SBQ)
repository.mail.fl_str_mv ||office@jbcs.sbq.org.br
_version_ 1750318179606855680